Fluoxetine during Development Reverses Prenatal Stress Effects
Author Information
Author(s): Rayen Ine van den Hove, Daniël L. Prickaerts, Jos Steinbusch, Harry W. Pawluski, Jodi L. Pawluski
Primary Institution: Maastricht University
Hypothesis
Does exposure to fluoxetine during development affect depressive-like behaviors and hippocampal neurogenesis in adolescent offspring of stressed mothers?
Conclusion
Maternal fluoxetine exposure can reverse the negative effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescent offspring.
Supporting Evidence
- Maternal fluoxetine exposure reversed the reduction in immobility in prenatally stressed offspring.
- Fluoxetine treatment increased hippocampal cell proliferation in stressed offspring.
- Prenatal stress led to increased anxiety-like behavior in male offspring.
Takeaway
Giving fluoxetine to stressed mother rats helps their babies feel less sad and grow more brain cells.
Methodology
The study used a rodent model with stressed and non-stressed rat dams treated with fluoxetine or vehicle, assessing offspring behavior and brain development.
Potential Biases
Potential bias in the interpretation of behavioral outcomes based on the treatment conditions.
Limitations
The study was conducted in a rodent model, which may not fully translate to humans.
Participant Demographics
Sprague-Dawley rats, both male and female offspring were included.
Statistical Information
P-Value
p≤0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website